Search | Page 16 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)

    ... Traditionally, very strong cancer treatment drugs ( chemotherapy ) and radiation are used to prepare a subject's body for ... attack the recipient's normal body. Recently, less intense chemotherapy and radiation regimens have been employed (these are called ...

    Clinical Trial last updated 04/27/2016 - 1:04pm.

  2. Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome

    ... that can be given safely when it is combined with two chemotherapy drugs ( fludarabine and cytarabine). This study will be ... participant's best interest based on disease progression. Chemotherapy may be delayed by 1-3 days if clinically indicated. Other ...

    Clinical Trial last updated 04/28/2016 - 9:48am.

  3. TBI Dose De-escalation for Fanconi Anemia

    ... -6). 2) Day -5 through Day -2, subjects will receive a chemotherapy regimen of Fludarabine and Cyclophosphamide ... Day -5 through Day -2, subjects will receive chemotherapy of Cyclophosphamide via central line (i.e. Hickman or Broviac),10 ...

    Clinical Trial last updated 04/28/2016 - 9:06am.

  4. Chronic Lymphocytic Leukemia (CLL)

    ... CLL patients who are treated with certain types of chemotherapy have an increased risk of developing myelodysplastic ...

    Topic section last updated 07/07/2016 - 3:18pm.

  5. Clinical Trials Report for November 2015

    ... identifier: NCT02281084 Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced ... clinical trial studies the feasibility of having induction chemotherapy in an outpatient setting. Patients with acute leukemia (AML) or ...

    Page last updated 10/30/2015 - 8:46am.

  6. Nonmyeloablative Allogeneic Transplant (Mini-allo)

    ... Cell Lymphoma (any Stage - must have received induction chemotherapy ) Multiple Myeloma (10% residual plasmacytosis following anthracycline-based chemotherapy or residual disease following autologous transplant) ...

    Clinical Trial last updated 04/28/2016 - 2:13pm.

  7. Causes

    ... arsenic and benzene Radiation and chemotherapy used to treat cancer Treatments for other autoimmune ...

    Topic section last updated 06/30/2016 - 9:46am.

  8. UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep

    ... hematologic malignancies not curable by conventional chemotherapy . Responses to conventional treatment range from zero to 30% ... lymphoma, Hodgkin lymphoma and multiple myeloma with chemotherapy sensitive disease who are ineligible for an autologous transplant. ...

    Clinical Trial last updated 04/29/2016 - 10:06am.

  9. Clinical Trials Report for October 2015

    ... identifier: NCT02281084 Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced ... clinical trial studies the feasibility of having induction chemotherapy in an outpatient setting. Patients with acute leukemia (AML) or ...

    Page last updated 09/30/2015 - 10:53am.

  10. A Phase III, International, Randomized, Controlled Study of Rigosertib versus Physician’s Choice of Treatment in Patients with Myelodysplastic Syndrome after Failure of a Hypomethylating Agent

    ... study b.         Eligible to receive induction chemotherapy , such as 7-10 days of cytosine arabinoside and 2-3 days of an ... Any other concurrent investigational agent or chemotherapy, radiotherapy, or immunotherapy, or corticosteroids ( ...

    Clinical Trial last updated 11/29/2016 - 8:29am.